Contravisory Investment Management’s Xerox XRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-471
Closed -$4.89K – 439
2024
Q3
$4.89K Buy
+471
New +$5.04K ﹤0.01% 314
2021
Q4
– Sell
-16,011
Closed -$323K – 329
2021
Q3
$323K Sell
16,011
-126
-0.8% -$2.86K 0.1% 152
2021
Q2
$379K Buy
16,137
+4,001
+33% +$96.8K 0.11% 122
2021
Q1
$295K Buy
+12,136
New +$290K 0.09% 135
2020
Q2
– Sell
-12,546
Closed -$238K – 338
2020
Q1
$238K Buy
12,546
+107
+0.9% +$3.4K 0.11% 110
2019
Q4
$459K Sell
12,439
-2
-0% -$70 0.17% 65
2019
Q3
$372K Sell
12,441
-112
-0.9% -$3.51K 0.14% 86
2019
Q2
$445K Buy
12,553
+15
+0.1% +$501 0.17% 65
2019
Q1
$401K Buy
+12,538
New +$354K 0.16% 81
2018
Q1
– Sell
-7,417
Closed -$216K – 465
2017
Q4
$216K Buy
7,417
+7,350
+10,970% +$223K 0.08% 134
2017
Q3
$2K Buy
+67
New +$2.11K ﹤0.01% 378
2017
Q2
– Sell
-68
Closed -$2K – 276
2017
Q1
$2K Sell
68
-34
-33% -$981 ﹤0.01% 267
2016
Q4
$2K Hold
102
– – ﹤0.01% 266
2016
Q3
$3K Buy
+102
New +$2.63K ﹤0.01% 243

Other funds holding XRX

Contravisory Investment Management's XRX Position: Q4 2024 in Review

Contravisory Investment Management sold out of Xerox (XRX) in Q4 2024, closing a stake of 471 shares — an estimated $4.89K sold.

Contravisory Investment Management first reported a position in XRX in Q3 2016 and held it in 14 quarters. The position peaked at $459K in Q4 2019. 284 funds tracked by Wall St. Rank hold XRX as of Q4 2024.

  • Contravisory Investment Management reported no remaining Xerox position as of Q4 2024 after selling out during the quarter.
  • Contravisory Investment Management sold 471 Xerox shares in Q4 2024, an estimated $4.89K.
  • Contravisory Investment Management first reported a position in Xerox in Q3 2016 and held it in 14 quarters.
  • Contravisory Investment Management's Xerox position peaked at $459K in Q4 2019.
  • 284 funds tracked by Wall St. Rank held Xerox as of Q4 2024.

Based on Contravisory Investment Management's 13F filing for Q4 2024, filed 14 Jan 2025.